Charles Schwab’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Buy |
1,916,486
+68,745
| +4% | +$118K | ﹤0.01% | 2502 |
|
|
2025
Q1 | $6.15M | Sell |
1,847,741
-141,599
| -7% | -$472K | ﹤0.01% | 2183 |
|
|
2024
Q4 | $14.7M | Buy |
1,989,340
+76,196
| +4% | +$564K | ﹤0.01% | 1845 |
|
|
2024
Q3 | $18M | Sell |
1,913,144
-71,801
| -4% | -$674K | ﹤0.01% | 1753 |
|
|
2024
Q2 | $15.9M | Buy |
1,984,945
+71,845
| +4% | +$576K | ﹤0.01% | 1803 |
|
|
2024
Q1 | $28.4M | Buy |
1,913,100
+166,077
| +10% | +$2.46M | 0.01% | 1402 |
|
|
2023
Q4 | $14.2M | Buy |
1,747,023
+54,490
| +3% | +$443K | ﹤0.01% | 1805 |
|
|
2023
Q3 | $7.7M | Buy |
1,692,533
+201,311
| +13% | +$916K | ﹤0.01% | 2053 |
|
|
2023
Q2 | $10.5M | Buy |
1,491,222
+435,370
| +41% | +$3.07M | ﹤0.01% | 1885 |
|
|
2023
Q1 | $6.45M | Buy |
1,055,852
+1,008
| +0.1% | +$6.16K | ﹤0.01% | 2086 |
|
|
2022
Q4 | $6.74M | Buy |
1,054,844
+27,384
| +3% | +$175K | ﹤0.01% | 2051 |
|
|
2022
Q3 | $9.84M | Buy |
1,027,460
+26,988
| +3% | +$259K | ﹤0.01% | 1840 |
|
|
2022
Q2 | $11M | Buy |
1,000,472
+292,976
| +41% | +$3.23M | ﹤0.01% | 1788 |
|
|
2022
Q1 | $11.8M | Buy |
707,496
+22,037
| +3% | +$367K | ﹤0.01% | 1860 |
|
|
2021
Q4 | $13.1M | Buy |
685,459
+19,563
| +3% | +$373K | ﹤0.01% | 1859 |
|
|
2021
Q3 | $16.4M | Sell |
665,896
-89,520
| -12% | -$2.21M | 0.01% | 1728 |
|
|
2021
Q2 | $19.7M | Buy |
755,416
+46,758
| +7% | +$1.22M | 0.01% | 1603 |
|
|
2021
Q1 | $22.4M | Buy |
708,658
+59,401
| +9% | +$1.88M | 0.01% | 1433 |
|
|
2020
Q4 | $30.1M | Buy |
649,257
+10,387
| +2% | +$482K | 0.01% | 1099 |
|
|
2020
Q3 | $21M | Buy |
638,870
+13,383
| +2% | +$441K | 0.01% | 1167 |
|
|
2020
Q2 | $17.2M | Sell |
625,487
-116,823
| -16% | -$3.21M | 0.01% | 1282 |
|
|
2020
Q1 | $22.2M | Buy |
742,310
+12,813
| +2% | +$384K | 0.01% | 943 |
|
|
2019
Q4 | $20.2M | Buy |
729,497
+28,564
| +4% | +$791K | 0.01% | 1205 |
|
|
2019
Q3 | $12.8M | Sell |
700,933
-1,321
| -0.2% | -$24K | 0.01% | 1443 |
|
|
2019
Q2 | $17.2M | Buy |
702,254
+34,480
| +5% | +$845K | 0.01% | 1240 |
|
|
2019
Q1 | $6.35M | Buy |
667,774
+29,194
| +5% | +$278K | ﹤0.01% | 1858 |
|
|
2018
Q4 | $5.65M | Buy |
638,580
+176,564
| +38% | +$1.56M | ﹤0.01% | 1841 |
|
|
2018
Q3 | $5.2M | Buy |
462,016
+55,324
| +14% | +$622K | ﹤0.01% | 2019 |
|
|
2018
Q2 | $5.21M | Buy |
406,692
+48,697
| +14% | +$623K | ﹤0.01% | 1978 |
|
|
2018
Q1 | $6.05M | Buy |
357,995
+55,820
| +18% | +$943K | ﹤0.01% | 1838 |
|
|
2017
Q4 | $2.42M | Buy |
302,175
+80,160
| +36% | +$641K | ﹤0.01% | 2243 |
|
|
2017
Q3 | $1.72M | Buy |
222,015
+12,883
| +6% | +$99.9K | ﹤0.01% | 2341 |
|
|
2017
Q2 | $1.54M | Buy |
209,132
+1,762
| +0.8% | +$13K | ﹤0.01% | 2314 |
|
|
2017
Q1 | $1.55M | Buy |
207,370
+11,220
| +6% | +$83.6K | ﹤0.01% | 2284 |
|
|
2016
Q4 | $1.36M | Buy |
196,150
+10,483
| +6% | +$72.9K | ﹤0.01% | 2325 |
|
|
2016
Q3 | $1.53M | Buy |
185,667
+26,290
| +16% | +$217K | ﹤0.01% | 2259 |
|
|
2016
Q2 | $1.29M | Buy |
159,377
+3,678
| +2% | +$29.8K | ﹤0.01% | 2257 |
|
|
2016
Q1 | $791K | Buy |
155,699
+4,001
| +3% | +$20.3K | ﹤0.01% | 2414 |
|
|
2015
Q4 | $1.17M | Buy |
151,698
+5,871
| +4% | +$45.4K | ﹤0.01% | 2319 |
|
|
2015
Q3 | $840K | Buy |
145,827
+9,363
| +7% | +$53.9K | ﹤0.01% | 2443 |
|
|
2015
Q2 | $1.25M | Buy |
+136,464
| New | +$1.25M | ﹤0.01% | 2316 |
|